Last reviewed · How we verify

NCT04310852: Bone-Gun

Knee Osteoarthritis Treatment With Percutaneous Injections of Autologous Bone Marrow Concentrate

Status unknown Last updated 17 March 2020
What this trial tests

trial testing BioCue Concentration Kit in Knee Osteoarthritis in 25 participants. Status unknown.

Timeline
6 June 2018
Primary endpoint
30 September 2021
31 January 2022

Quick facts

Lead sponsorIstituto Clinico Humanitas
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment25
Start date6 June 2018
Primary completion30 September 2021
Estimated completion31 January 2022
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Istituto Clinico Humanitas

Who can join

Adults 40 to 70, any sex, with Knee Osteoarthritis or Cartilage Degeneration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recently there has been a growing interest in the role of subchondral bone in knee arthritis, both in its etiology and evolution and in its clinical significance. It has now been widely demonstrated that changes in the subchondral bone can develop both as a cause and as a consequence of joint degeneration and it is now accepted in the scientific community that the presence of these changes is of clinical importance, causing pain and an inflammatory state that can contribute to the evolution of arthrosis arthropathy. Recently the use of mesenchymal cells obtained from the bone marrow has been proposed for the treatment of gonarthrosis by intra-articular injections. Even more recently, treatments have been studied and proposed for the treatment of the bone-cartilage interface in knees affected by osteoarthrosis, using autologous bone marrow concentrate, with promising results.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other Istituto Clinico Humanitas trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04310852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing